Long Non-Coding RNA ZSCAN16-AS1 Promotes the Malignant Progression of Melanoma Through Regulating the miR-503-5p/ARL2 Axis

References

• Ahmed B, Qadir MI, Ghafoor S. Malignant melanoma: skin cancer-diagnosis, prevention, and treatment. Crit Rev Eukaryot Gene Expr. 2020;30(4):291–297.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584–590.
   PubMed Web of Science ®Google Scholar
• Kozovska Z, Gabrisova V, Kucerova L. Malignant melanoma: diagnosis, treatment and cancer stem cells. Neoplasma. 2016;63(4):510–517.
   PubMed Web of Science ®Google Scholar
• Paluncic J, Kovacevic Z, Jansson PJ, et al. Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling. Biochim Biophys Acta. 2016;1863(4):770–784.
   PubMed Web of Science ®Google Scholar
• Lu H, Liu S, Zhang G, et al. PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas. Nature. 2017;550(7674):133–136.
   PubMed Web of Science ®Google Scholar
• Elgar G, Vavouri T. Tuning in to the signals: noncoding sequence conservation in vertebrate genomes. Trends Genet. 2008;24(7):344–352.
   PubMed Web of Science ®Google Scholar
• Li T, Mo X, Fu L, Xiao B, Guo J. Molecular mechanisms of long noncoding RNAs on gastric cancer. Oncotarget. 2016;7(8):8601–8612.
   PubMedGoogle Scholar
• Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542–551.
   PubMed Web of Science ®Google Scholar
• Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
   PubMed Web of Science ®Google Scholar
• Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339–346.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu R, Liu Y, et al. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway. Cell Cycle. 2021;20(12):1134–1146.
   PubMed Web of Science ®Google Scholar
• Lv C, Wan Q, Shen C, Wu H, Zhou B, Wang W. Long non‑coding RNA ZSCAN16‑AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA‑451a and consequently increasing ATF2 expression. Mol Med Rep. 2021;24(5):67.
   Web of Science ®Google Scholar
• Ding Y, Li M, Tayier T, Zhang M, Chen L, Feng S. Bioinformatics analysis of lncRNA‑associated ceRNA network in melanoma. J Cancer. 2021;12(10):2921–2932.
   PubMed Web of Science ®Google Scholar
• Cheng JT, Wang L, Wang H, et al. Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition. Cells. 2019;8(10):35.
   PubMed Web of Science ®Google Scholar
• Khorkova O, Hsiao J, Wahlestedt C. Basic biology and therapeutic implications of lncRNA. Adv Drug Deliv Rev. 2015;87:15–24.
   PubMed Web of Science ®Google Scholar
• Lingadahalli S, Jadhao S, Sung YY, et al. Novel lncRNA LINC00844 Regulates Prostate Cancer Cell Migration and Invasion through AR Signaling. Mol Cancer Res. 2018;16(12):1865–1878.
   PubMed Web of Science ®Google Scholar
• Wang Y, Guan G, Cheng W, et al. ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL. BMC Cancer. 2018;18(1):599.
   PubMedGoogle Scholar
• Chen L, Zhang X, Wang S, Lin X, Xu L. Circ_0084927 Facilitates Cervical Cancer Development via Sponging miR-142-3p and Upregulating ARL2. Cancer Manag Res. 2020;12:9271–9283.
   PubMed Web of Science ®Google Scholar
• Beghin A, Belin S, Hage-Sleiman R, et al. ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice. PLoS One. 2009;4(10):e7478.
   PubMed Web of Science ®Google Scholar
• Liu H, Dai C, Wu Q, Liu H, Li F. Expression profiling of long noncoding RNA identifies lnc-MMP3-1 as a prognostic biomarker in external auditory canal squamous cell carcinoma. Cancer Med. 2017;6(11):2541–2551.
   PubMed Web of Science ®Google Scholar
• Subramanian M, Li XL, Hara T, Lal A. A biochemical approach to identify direct microRNA targets. Methods Mol Biol. 2015;1206:29–37.
   PubMedGoogle Scholar
• Zhang X, Wang W, Zhu W, et al. Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int J Mol Sci. 2019;20(22):85.
   Web of Science ®Google Scholar
• Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29(4):452–463.
   PubMed Web of Science ®Google Scholar
• Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914.
   PubMed Web of Science ®Google Scholar
• Xing YH, Bai Z, Liu CX, Hu SB, Ruan M, Chen LL. Research progress of long noncoding RNA in China. IUBMB Life. 2016;68(11):887–893.
   PubMed Web of Science ®Google Scholar
• Liu L, Shi Y, Shi J, et al. The long non-coding RNA SNHG1 promotes glioma progression by competitively binding to miR-194 to regulate PHLDA1 expression. Cell Death Dis. 2019;10(6):463.
   PubMedGoogle Scholar
• Pandey GK, Kanduri C. Long Non-Coding RNAs: tools for Understanding and Targeting Cancer Pathways. Cancers. 2022;14(19):4760.
   PubMed Web of Science ®Google Scholar
• Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2).:56
   Web of Science ®Google Scholar
• Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358–369.
   PubMed Web of Science ®Google Scholar
• Denzler R, Agarwal V, Stefano J, Bartel DP, Stoffel M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell. 2014;54(5):766–776.
   PubMed Web of Science ®Google Scholar
• Matozaki T, Nakanishi H, Takai Y. Small G-protein networks: their crosstalk and signal cascades. Cell Signal. 2000;12(8):515–524.
   PubMed Web of Science ®Google Scholar
• Bhamidipati A, Lewis SA, Cowan NJ. ADP ribosylation factor-like protein 2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin. J Cell Biol. 2000;149(5):1087–1096.
   PubMed Web of Science ®Google Scholar
• Sharer JD, Shern JF, Van Valkenburgh H, Wallace DC, Kahn RA. ARL2 and BART enter mitochondria and bind the adenine nucleotide transporter. Mol Biol Cell. 2002;13(1):71–83.
   PubMed Web of Science ®Google Scholar
• Newman LE, Zhou CJ, Mudigonda S, et al. The ARL2 GTPase is required for mitochondrial morphology, motility, and maintenance of ATP levels. PLoS One. 2014;9(6):e99270.
   PubMed Web of Science ®Google Scholar
• Muromoto R, Sekine Y, Imoto S, et al. BART is essential for nuclear retention of STAT3. Int Immunol. 2008;20(3):395–403.
   PubMed Web of Science ®Google Scholar
• Hass HG, Vogel U, Scheurlen M, Jobst J. Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular Carcinoma. Anticancer Res. 2016;36(10):5087–5095.
   PubMed Web of Science ®Google Scholar
• Taniuchi K, Iwasaki S, Saibara T. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation. Int J Oncol. 2011;39(5):1243–1252.
   PubMed Web of Science ®Google Scholar
• Sun Z, Li A, Yu Z, Li X, Guo X, Chen R. MicroRNA-497-5p Suppresses Tumor Cell Growth of Osteosarcoma by Targeting ADP Ribosylation Factor-Like Protein 2. Cancer Biother Radiopharm. 2017;32(10):371–378.
   PubMed Web of Science ®Google Scholar
• Liu W, Yao D, Huang B. LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression. Open Life Sci. 2021;16(1):1–13.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun C, Zhang Y, Han N, Sun S. miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A. Gene Ther. 2022;29(1–2):28–40.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang F, Li H, et al. Circ_0010220-mediated miR-503-5p/CDCA4 axis contributes to osteosarcoma progression tumorigenesis. Gene. 2020;763:145068.
   PubMed Web of Science ®Google Scholar
• Tagliaferri L, Lancellotta V, Fionda B, et al. Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review. Hum Vaccin Immunother. 2022;18(3):1903827.
   PubMed Web of Science ®Google Scholar